See also this year's filing and all EDGAR filings for this company.
PDF Report 0001492422_2018_Apellis_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001492422, Apellis Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 182,015,306 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 116,150 |
| 4 | LiabilitiesCurrent | 6,553,958 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 26,634,638 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 153,692 |
| 11 | remainder_Revenues | 11,542 |
| 12 | remainder_NetIncome | -50,863,944 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 182,131,456 |
| 1 | Liabilities | 33,188,596 |
| 2 | Expenses | 153,692 |
| 3 | Revenues | 11,542 |
| 4 | StockholdersEquity | 148,942,860 |
| 5 | NetIncome | -51,006,094 |
| 6 | ComprehensiveNetIncome | -51,006,094 |
| 7 | BaseVar | 133,174,615 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.54 |
| 9 | EconomicCapitalRatio | 3.38 |
Edgar->Model Mapping
Feature Distribution
